Why Did My Testosterone Rise After Stopping TRT? (TRT Q&As)
Timeline
Dr. O’Connor explains that the heart attack itself is unlikely to have caused the increase and focuses on major lifestyle changes after the event, including weight loss, substantially better sleep, retirement, and reduced stress. He also stresses that testosterone can vary between measurements and should be interpreted using multiple readings and the overall clinical picture.
Dr. O’Connor explains that confirmed hereditary hemochromatosis requires careful evaluation before adding androgen therapy because increased red blood cell production could compound an existing iron-related problem. He recommends confirming the genetic diagnosis, reviewing baseline hemoglobin and hematocrit, managing iron appropriately, and carefully weighing whether androgen treatment is necessary.
The member says telmisartan controlled his blood pressure well but was stopped after elevated potassium, and his pressure has risen on another medication. Dr. O’Connor questions whether a single mildly elevated potassium result justified abandoning telmisartan and discusses repeating the test, evaluating kidney function and other causes, and working with his physician to individualize treatment.
Dr. O’Connor says he supports HCG when there is a specific reason, particularly fertility or maintaining testicular function, but does not believe every man on TRT automatically needs it. For an older man who is not trying to preserve fertility, he questions whether lifelong HCG provides enough benefit to justify the additional injections, cost, and complexity.
Video Summary
The discussion focuses on situations where testosterone therapy does not deliver expected symptom improvement. It emphasizes reviewing laboratory variability, dosing consistency, and lifestyle contributors before modifying treatment. Testosterone therapy is framed as one factor within a broader clinical picture.
A central segment explores why laboratory values can fluctuate despite stable dosing. The episode explains how timing, hydration, and physiologic variability affect interpretation. Overreaction to short-term lab changes is discouraged.
The closing portion integrates testosterone therapy into comprehensive long-term care. Individualized reassessment, risk awareness, and patience are emphasized as therapy evolves. Hormone therapy is positioned as a longitudinal clinical process.
Drug Callouts
Condition Callouts
Key Takeaways
- Persistent symptoms on testosterone therapy warrant comprehensive reassessment.
- Laboratory variability requires context before intervention.
- Non-hormonal factors often influence perceived response.
- Avoiding premature escalation supports stability.
- Long-term testosterone care depends on ongoing monitoring.